سرطان پانکراس

35
راس ک ن ا ن رطان س ان ی م ی ک ح ا مدرض ح م د ی س ر کت د ی م و م ع ی ح را( ج ص ص خ ت م رطان س ی ح را( ج پ ی1 س و ل ف

Upload: ivrit

Post on 24-Feb-2016

114 views

Category:

Documents


0 download

DESCRIPTION

سرطان پانکراس. دکتر سیدمحمدرضا حکیمیان متخصص جراحی عمومی فلوشیپ جراحی سرطان. Types: . Neoplasms of the Endocrine Pancreas(25%) Neoplasms of the Exocrine Pancreas(75%) 75% arise within the head or uncinate process of the pancreas; l5 % are in the body, 10% are in the tail. Staging. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: سرطان پانکراس

پانکراس سرطان

حکیمیان سیدمحمدرضا دکترعمومی جراحی متخصصسرطان جراحی فلوشیپ

Page 2: سرطان پانکراس

Types:

• Neoplasms of the Endocrine Pancreas(25%)

• Neoplasms of the Exocrine Pancreas(75%)• 75% arise within the head or uncinate process of

the pancreas;• l5 % are in the body,• 10% are in the tail

Page 3: سرطان پانکراس

Staging

Page 4: سرطان پانکراس

Diagnosis & stage:

• 7% percent of pancreas cancer cases are diagnosed while the cancer is still confined to the primary site (localized stage);

• 26% are diagnosed after the cancer has spread to regional lymph nodes or directly beyond the primary site

• 52% are diagnosed after the cancer has already metastasized (distant stage); and

• for the remaining l5% the staging information was unknown.

Page 5: سرطان پانکراس

Diagnosis:

• History & Ph Ex• CT scan (the single most versatile and costeffective

tool for the diagnosis)• Sonography • MRI• Endosono• LFT• CA19-9• laparoscopy

Page 6: سرطان پانکراس

Multislice, dynamic, contrast-enhanced CT with IV & oral contrast (pancreas protocol)• accuracy of CT scanning for predicting unresectable disease is about

90 to 95%• invasion of the hepatic or superior mesenteric artery, • enlarged lymph nodes outside the boundaries of resection, • ascites, and • distant metastases (e.g., liver).• Invasion of the superior mesenteric vein or portal vein is not in itself

a contraindication to resection as long as the veins are patent.• C T scanning is less accurate in predicting resectable diseas• When all of the current staging modalities are used, their accuracy in

predicting resectability is reported to be about 80%. 98% when laparoscopy with US is used.

Page 7: سرطان پانکراس
Page 8: سرطان پانکراس

Paliative surgery: • Jaundice & pruritus ; stent with ERCP, PTC drinage

(choledochojejunostomy is the preferred approach)• Duodenal obstruction (no bypass in the absence of

signs or symptomes. Roux-en-Y limb with the gastrojejunostomy located 50 cm downstream or a loop of jejunum with a jejunojejunostomy to divert the enteric stream away from the biliary-enteric anastomosis )

• Pain (celiac plexus nerve block)

Page 9: سرطان پانکراس
Page 10: سرطان پانکراس
Page 11: سرطان پانکراس

Curative surgery

Page 12: سرطان پانکراس

Technique:• Complication rate: 31%• pancreatic leakage rate: about 10%• mortality rate for pancreaticoduodenectomy is <5%

in "high volume" centers (where individual surgeons perform more than 15 cases per year)

Page 13: سرطان پانکراس
Page 14: سرطان پانکراس
Page 15: سرطان پانکراس
Page 16: سرطان پانکراس
Page 17: سرطان پانکراس
Page 18: سرطان پانکراس
Page 19: سرطان پانکراس
Page 20: سرطان پانکراس
Page 21: سرطان پانکراس
Page 22: سرطان پانکراس
Page 23: سرطان پانکراس
Page 24: سرطان پانکراس
Page 25: سرطان پانکراس
Page 26: سرطان پانکراس
Page 27: سرطان پانکراس

• transpancreatic U-suture technique (Blumgart anastomosis)

Page 28: سرطان پانکراس
Page 29: سرطان پانکراس
Page 30: سرطان پانکراس
Page 31: سرطان پانکراس
Page 32: سرطان پانکراس
Page 33: سرطان پانکراس
Page 34: سرطان پانکراس

total 1392(10m) 1391(12m)

29 13 16 N.O.

6(20%) 2(15%) 4 (25%) leak

4(13%) 0(0%) 4(25%) mortality

Page 35: سرطان پانکراس